Home News

Signet Therapeutics gets a $10M top-up for next-gen cancer bets

November 4, 2021

Signet Therapeutics gets a $10M top-up for next-gen cancer bets
badams
Fri, 10/29/2021 – 08:39

Read the source article at fiercebiotech.com
2021-10-29 13:23:24

Advantages of Early Minimally Invasive Surgery for Intracerebral Hemorrhage

Advantages of Early Minimally Invasive Surgery for Intracerebral Hemorrhage

April 11, 2024

Ionis Pharma Advances Olezarsen Towards Launch for Rare Disease Treatment Following Promising Trial Results

Ionis Pharma Advances Olezarsen Towards Launch for Rare Disease Treatment Following Promising Trial Results

April 9, 2024

Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy

Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy

March 28, 2024

Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers

Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers

March 27, 2024

GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients

GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients

March 7, 2024

Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues

Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues

March 4, 2024